Astragaloside IV Exerts a Myocardial Protective Effect against Cardiac Hypertrophy in Rats, Partially via Activating the Nrf2/HO-1 Signaling Pathway

Previous evidence suggested that astragaloside IV (ASIV) had a cardioprotective effect, but the potential mechanisms were undetermined. This study is aimed at validating the prevention of cardiac hypertrophy in chronic heart failure (CHF) rats and hypertrophy in H9c2 cardiomyocytes by ASIV and at ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Pei, Meng, Fanjing, Zhang, Jinguo, Wei, Xiqing, Shen, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594267/
https://www.ncbi.nlm.nih.gov/pubmed/31285785
http://dx.doi.org/10.1155/2019/4625912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594267/
https://www.ncbi.nlm.nih.gov/pubmed/31285785
http://dx.doi.org/10.1155/2019/4625912

Ejemplares similares